| Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 E Nichols, CEI Szoeke, SE Vollset, N Abbasi, F Abd-Allah, J Abdela, ... The Lancet Neurology 18 (1), 88-106, 2019 | 2072 | 2019 |
| Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 VL Feigin, E Nichols, T Alam, MS Bannick, E Beghi, N Blake, ... The Lancet Neurology 18 (5), 459-480, 2019 | 1727 | 2019 |
| Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 D Dicker, G Nguyen, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1684-1735, 2018 | 952 | 2018 |
| Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 CJL Murray, CSKH Callender, XR Kulikoff, V Srinivasan, D Abate, ... The Lancet 392 (10159), 1995-2051, 2018 | 286 | 2018 |
| Design and synthesis of novel quinazolinone-1, 2, 3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study M Saeedi, M Mohammadi-Khanaposhtani, P Pourrabia, N Razzaghi, ... Bioorganic chemistry 83, 161-169, 2019 | 140 | 2019 |
| One-pot synthesis and antibacterial activities of pyrazolo [4′, 3′: 5, 6] pyrido [2, 3-d] pyrimidine-dione derivatives A Bazgir, MM Khanaposhtani, AA Soorki Bioorganic & medicinal chemistry letters 18 (21), 5800-5803, 2008 | 138 | 2008 |
| Potent acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and docking study of acridone linked to 1, 2, 3-triazole derivatives M Mohammadi-Khanaposhtani, M Saeedi, NS Zafarghandi, M Mahdavi, ... European journal of medicinal chemistry 92, 799-806, 2015 | 112 | 2015 |
| Design, synthesis, pharmacological evaluation, and docking study of new acridone-based 1, 2, 4-oxadiazoles as potential anticonvulsant agents M Mohammadi-Khanaposhtani, M Shabani, M Faizi, I Aghaei, R Jahani, ... European journal of medicinal chemistry 112, 91-98, 2016 | 95 | 2016 |
| Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano [3, 2-c] quinoline derivatives as potential anti-diabetic agents H Nikookar, M Mohammadi-Khanaposhtani, S Imanparast, MA Faramarzi, ... Bioorganic chemistry 77, 280-286, 2018 | 83 | 2018 |
| New 6-amino-pyrido [2, 3-d] pyrimidine-2, 4-diones as novel agents to treat type 2 diabetes: a simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and … M Adib, F Peytam, M Rahmanian-Jazi, S Mahernia, HR Bijanzadeh, ... European Journal of Medicinal Chemistry 155, 353-363, 2018 | 82 | 2018 |
| Biscoumarin-1, 2, 3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies MS Asgari, M Mohammadi-Khanaposhtani, M Kiani, PR Ranjbar, E Zabihi, ... Bioorganic chemistry 92, 103206, 2019 | 75 | 2019 |
| Design, synthesis, biological evaluation, and docking study of acetylcholinesterase inhibitors: New acridone‐1, 2, 4‐oxadiazole‐1, 2, 3‐triazole hybrids M Mohammadi‐Khanaposhtani, M Mahdavi, M Saeedi, R Sabourian, ... Chemical biology & drug design 86 (6), 1425-1432, 2015 | 74 | 2015 |
| Synthesis and biological evaluation of new benzimidazole-1, 2, 3-triazole hybrids as potential α-glucosidase inhibitors N Asemanipoor, M Mohammadi-Khanaposhtani, S Moradi, M Vahidi, ... Bioorganic chemistry 95, 103482, 2020 | 61 | 2020 |
| Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes M Mohammadi-Khanaposhtani, S Rezaei, R Khalifeh, S Imanparast, ... Bioorganic Chemistry 80, 288-295, 2018 | 60 | 2018 |
| A review on synthesis, mechanism of action, and structure-activity relationships of 1, 2, 3-triazole-based α-glucosidase inhibitors as promising anti-diabetic agents Z Fallah, M Tajbakhsh, M Alikhani, B Larijani, MA Faramarzi, H Hamedifar, ... Journal of Molecular Structure 1255, 132469, 2022 | 54 | 2022 |
| Design, synthesis and in vitro α-glucosidase inhibition of novel coumarin-pyridines as potent antidiabetic agents M Adib, F Peytam, M Rahmanian-Jazi, M Mohammadi-Khanaposhtani, ... New Journal of Chemistry 42 (21), 17268-17278, 2018 | 54 | 2018 |
| Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivatives K Pedrood, M Sherafati, M Mohammadi-Khanaposhtani, MS Asgari, ... International Journal of Biological Macromolecules 170, 1-12, 2021 | 51 | 2021 |
| Synthesis, characterization, molecular docking, and biological activities of coumarin–1, 2, 3‐triazole‐acetamide hybrid derivatives N Sepehri, M Mohammadi‐Khanaposhtani, N Asemanipoor, S Hosseini, ... Archiv der Pharmazie 353 (10), 2000109, 2020 | 51 | 2020 |
| Design, synthesis, in vitro cytotoxic activity evaluation, and apoptosis-induction study of new 9(10H)-acridinone-1,2,3-triazoles M Mohammadi-Khanaposhtani, M Safavi, R Sabourian, M Mahdavi, ... Molecular diversity 19, 787-795, 2015 | 50 | 2015 |
| Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1, 2, 3-triazole hybrids as potent α-glucosidase inhibitors M Saeedi, M Mohammadi-Khanaposhtani, MS Asgari, N Eghbalnejad, ... Bioorganic & medicinal chemistry 27 (23), 115148, 2019 | 39 | 2019 |
Mohammad MahdaviAssistant Professor of Endocrinology & Metabolism Research Institute,Tehran University of MedicalVerified email at tums.ac.ir
